Immunochemotherapy triggered reversible cerebral vasoconstriction syndrome in a patient with intravascular large B-cell lymphoma

Leuk Lymphoma. 2024 Jun;65(6):848-851. doi: 10.1080/10428194.2024.2316252. Epub 2024 Feb 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols* / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / complications
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Middle Aged
  • Syndrome
  • Vascular Neoplasms / complications
  • Vascular Neoplasms / diagnosis
  • Vascular Neoplasms / drug therapy
  • Vasoconstriction / drug effects